PMC Links for Books (Select 4857610) - PMC

Select item 102309471.

Nicholas J Short, Michael E Rytting, Jorge E Cortes

Lancet. Author manuscript; available in PMC 2023 May 31.

Published in final edited form as: Lancet. 2018 Aug 18; 392(10147): 593–606. Published online 2018 Aug 2. doi: 10.1016/S0140-6736(18)31041-9

PMCID:: PMC10230947

Abstract Article PDF–657K

Select item 91140402.

Analysis of risk factors for hepatic sinusoidal obstruction syndrome following allogeneic hematopoietic stem cell transplantation in pediatric patients

Jaspar Kloehn, Grit Brodt, Jana Ernst, Bernd Gruhn

J Cancer Res Clin Oncol. 2022; 148(6): 1447–1455. Published online 2021 Jul 13. doi: 10.1007/s00432-021-03732-1

PMCID:: PMC9114040

Abstract Article PDF–560K

Select item 83240763.

Veno-occlusive disease risk in pediatric patients with acute myeloid leukemia treated with gemtuzumab ozogamicin before allogeneic hematopoietic cell transplantation

Christine Duncan, Andrew St. Martin, Waleska S. Pérez, Patricia Steinert, Mei-Jie Zhang, Deborah Chirnomas, Caroline J. Hoang, Fausto R. Loberiza, Jr, Wael Saber

Pediatr Blood Cancer. Author manuscript; available in PMC 2022 Aug 1.

Published in final edited form as: Pediatr Blood Cancer. 2021 Aug; 68(8): e29067. Published online 2021 Apr 19. doi: 10.1002/pbc.29067

PMCID:: PMC8324076

Abstract Article PDF–331K

Select item 75584674.

Antibody–Drug Conjugates: The Last Decade

Nicolas Joubert, Alain Beck, Charles Dumontet, Caroline Denevault-Sabourin

Pharmaceuticals (Basel) 2020 Sep; 13(9): 245. Published online 2020 Sep 14. doi: 10.3390/ph13090245

PMCID:: PMC7558467

Abstract Article PDF–7.8M

Select item 74391345.

Prior Gemtuzumab Ozogamicin Exposure in Adults With Acute Myeloid Leukemia Does Not Increase Hepatic Veno-occlusive Disease Risk After Allogeneic Hematopoietic Cell Transplantation: a CIBMTR Analysis

Vincent T Ho, Andrew St. Martin, Waleska S Pérez, Patricia Steinert, Mei-Jie Zhang, Deborah Chirnomas, Caroline J Hoang, Fausto R Loberiza, Jr, Wael Saber

Biol Blood Marrow Transplant. Author manuscript; available in PMC 2021 May 1.

Published in final edited form as: Biol Blood Marrow Transplant. 2020 May; 26(5): 884–892. Published online 2019 Dec 28. doi: 10.1016/j.bbmt.2019.12.763

PMCID:: PMC7439134

Abstract Article PDF–124K

Select item 70308906.

Gemtuzumab Ozogamicin in NPM1-Mutated Acute Myeloid Leukemia: Early Results From the Prospective Randomized AMLSG 09-09 Phase III Study

Richard F. Schlenk, Peter Paschka, Julia Krzykalla, Daniela Weber, Silke Kapp-Schwoerer, Verena I. Gaidzik, Claudia Leis, Walter Fiedler, Thomas Kindler, Thomas Schroeder, Karin Mayer, Michael Lübbert, Mohammed Wattad, Katharina Götze, Heinz A. Horst, Elisabeth Koller, Gerald Wulf, Jan Schleicher, Martin Bentz, Richard Greil, Bernd Hertenstein, Jürgen Krauter, Uwe Martens, David Nachbaur, Maisun Abu Samra, Michael Girschikofsky, Nadezda Basara, Axel Benner, Felicitas Thol, Michael Heuser, Arnold Ganser, Konstanze Döhner, Hartmut Döhner

J Clin Oncol. 2020 Feb 20; 38(6): 623–632. Published online 2019 Dec 18. doi: 10.1200/JCO.19.01406

PMCID:: PMC7030890

Abstract Article PDF–1.1M

Select item 65161237.

The EMA Review of Mylotarg (Gemtuzumab Ozogamicin) for the Treatment of Acute Myeloid Leukemia

Sahra Ali, Helen‐Marie Dunmore, Dominik Karres, Justin L. Hay, Tomas Salmonsson, Christian Gisselbrecht, Sinan B. Sarac, Ole W. Bjerrum, Doris Hovgaard, Yolanda Barbachano, Nithyanandan Nagercoil, Francesco Pignatti

Oncologist. 2019 May; 24(5): e171–e179. Published online 2019 Mar 21. doi: 10.1634/theoncologist.2019-0025

PMCID:: PMC6516123

Abstract Article PDF–1.0M

Select item 63120108.

Gemtuzumab ozogamicin for de novo acute myeloid leukemia: final efficacy and safety updates from the open-label, phase III ALFA-0701 trial

Juliette Lambert, Cécile Pautas, Christine Terré, Emmanuel Raffoux, Pascal Turlure, Denis Caillot, Ollivier Legrand, Xavier Thomas, Claude Gardin, Karïn Gogat-Marchant, Stephen D. Rubin, Rebecca J. Benner, Pierre Bousset, Claude Preudhomme, Sylvie Chevret, Herve Dombret, Sylvie Castaigne

Haematologica. 2019 Jan; 104(1): 113–119. Prepublished online 2018 Aug 3. doi: 10.3324/haematol.2018.188888

PMCID:: PMC6312010

Abstract Article PDF–360K

Select item 61926089.

FDA Approval Summary: Mylotarg for Treatment of Patients with Relapsed or Refractory CD33‐Positive Acute Myeloid Leukemia

Kelly J. Norsworthy, Chia‐Wen Ko, Jee Eun Lee, Jiang Liu, Christy S. John, Donna Przepiorka, Ann T. Farrell, Richard Pazdur

Oncologist. 2018 Sep; 23(9): 1103–1108. Published online 2018 Apr 12. doi: 10.1634/theoncologist.2017-0604

PMCID:: PMC6192608

Abstract Article PDF–320K

Select item 460449510.

Idarubicin and cytarabine in combination with gemtuzumab ozogamicin (IAGO) for untreated patients with high-risk MDS or AML evolved from MDS: a phase II study from the EORTC and GIMEMA Leukemia Groups (protocol 06013)

Theo de Witte, Stefan Suciu, Liv Meert, Constantijn Halkes, Dominik Selleslag, Dominique Bron, Sergio Amadori, Roel Willemze, Petra Muus, Frédéric Baron

Ann Hematol. 2015; 94(12): 1981–1989. Published online 2015 Sep 26. doi: 10.1007/s00277-015-2486-9

PMCID:: PMC4604495

Abstract Article PDF–579K

Select item 444623511.

Features and Outcomes of 899 Patients with Drug-induced Liver Injury: The DILIN Prospective Study

N Chalasani, HL Bonkovsky, R Fontana, W Lee, A Stolz, J Talwalkar, KR Reddy, PB Watkins, V Navarro, H Barnhart, J Gu, J Serrano, for the United States Drug Induced Liver Injury Network

Gastroenterology. Author manuscript; available in PMC 2016 Jun 1.

Published in final edited form as: Gastroenterology. 2015 Jun; 148(7): 1340–1352.e7. Published online 2015 Mar 6. doi: 10.1053/j.gastro.2015.03.006

PMCID:: PMC4446235

Abstract Article PDF–546K

Select item 399225012.

Drug-Induced Acute Liver Failure: Results of a U.S. Multicenter, Prospective Study

Adrian Reuben, David G. Koch, William M. Lee, the Acute Liver Failure Study Group

Hepatology. Author manuscript; available in PMC 2014 Apr 20.

Published in final edited form as: Hepatology. 2010 Dec; 52(6): 2065–2076. Published online 2010 Oct 14. doi: 10.1002/hep.23937

PMCID:: PMC3992250

Abstract Article PDF–328K

PMC

Result Filters

Article attributes

Text availability

Publication date

Custom date range

Research Funder

Additional filters

Display Settings:

Send to:

Links from Books

Items: 12

Display Settings:

Send to:

Supplemental Content

Find related data

Recent activity